Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 21:43 | 2026-05-19 | CVS | CVS HEALTH Corp | ROBBINS LARRY | Director | Retail-Drug Stores and Proprietary Stores | SALE | $94.15 | 3,372,000 | $317,471,102 | 4,824,799 | -41.1% |
| 2026-05-11 21:27 | 2026-05-08 | CVS | CVS HEALTH Corp | Mandadi Tilak | Officer; EVP, Chief Exp & Tech Officer | Retail-Drug Stores and Proprietary Stores | SALE | $89.58 | 69,551 | $6,230,379 | 10,133 | -87.3% |
| 2026-01-28 01:20 | 2025-01-23 | CVS | CVS HEALTH Corp | Nelson Steven H | Officer; EVP and President, Aetna | Retail-Drug Stores and Proprietary Stores | BUY | $53.70 | 24 | $1,289 | 24 | +100.0% |
| 2025-10-15 02:08 | 2024-09-09 | CVS | CVS HEALTH Corp | CAPOZZI HEIDI B | Officer; EVP and Chief People Officer | Retail-Drug Stores and Proprietary Stores | BUY | $57.36 | 80 | $4,589 | 85 | +1,600.0% |
| 2025-08-29 23:29 | 2025-08-20 | CVS | CVS HEALTH Corp | Finucane Anne A. | Director | Retail-Drug Stores and Proprietary Stores | SALE | $71.02 | 7,500 | $532,650 | 22,156 | -25.3% |
| 2025-06-09 15:22 | 2025-06-05 | CVS | CVS HEALTH Corp | SANSONE GUY P | Director | Retail-Drug Stores and Proprietary Stores | BUY | $63.70 | 1,570 | $100,009 | 12,007 | +15.0% |
| 2025-05-06 23:15 | 2025-05-02 | CVS | CVS HEALTH Corp | ROBBINS LARRY | Director | Retail-Drug Stores and Proprietary Stores | SALE | $67.65 | 3,750,000 | $253,695,375 | 8,196,799 | -31.4% |
| 2025-03-08 00:56 | 2025-03-05 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $66.35 | 7,513 | $498,488 | 8,394 | -47.2% |
| 2025-02-19 20:35 | 2025-02-18 | CVS | CVS HEALTH Corp | Mahoney Michael F | Director | Retail-Drug Stores and Proprietary Stores | BUY | $66.70 | 30,000 | $2,001,000 | 39,356 | +320.6% |
| 2024-05-02 23:30 | 2024-05-02 | CVS | CVS HEALTH Corp | Mahoney Michael F | Director | Retail-Drug Stores and Proprietary Stores | BUY | $54.49 | 9,181 | $500,294 | 9,356 | +5,246.3% |
| 2024-05-02 23:31 | 2024-05-02 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | Retail-Drug Stores and Proprietary Stores | BUY | $53.88 | 1,000 | $53,879 | 21,630 | +4.8% |
| 2024-02-17 02:46 | 2024-02-16 | CVS | CVS HEALTH Corp | Shah Prem S | Officer; EVP and Pres-Pharm, Consumer W | Retail-Drug Stores and Proprietary Stores | SALE | $76.95 | 29,473 | $2,267,947 | 39,765 | -42.6% |
| 2023-11-06 18:59 | 2023-11-03 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | Retail-Drug Stores and Proprietary Stores | BUY | $70.47 | 2,000 | $140,930 | 20,630 | +10.7% |
| 2023-08-05 00:41 | 2023-08-03 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | SALE | $74.92 | 25,759 | $1,930,004 | 4,698 | -84.6% |
| 2023-05-05 15:27 | 2023-05-03 | CVS | CVS HEALTH Corp | Lynch Karen S | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | BUY | $69.75 | 14,000 | $976,567 | 431,392 | +3.4% |
| 2022-12-17 00:14 | 2022-12-15 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $98.36 | 137,466 | $13,521,183 | 608,129 | -18.4% |
| 2022-08-05 23:48 | 2022-08-03 | CVS | CVS HEALTH Corp | Finke Daniel P | Officer; EVP/Pres, Health Care Benefits | Retail-Drug Stores and Proprietary Stores | OPT+S | $100.00 | 9,546 | $954,600 | 32,150 | -22.9% |
| 2022-08-05 23:50 | 2022-08-03 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP&President-PharmacyServices | Retail-Drug Stores and Proprietary Stores | OPT+S | $98.94 | 143,440 | $14,192,370 | 109,183 | -56.8% |
| 2022-07-01 00:00 | 2022-06-28 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $95.00 | 138,654 | $13,172,130 | 626,273 | -18.1% |
| 2022-04-12 23:51 | 2022-04-08 | CVS | CVS HEALTH Corp | Shah Prem S | Officer; EVP and Co-President of Retail | Retail-Drug Stores and Proprietary Stores | OPT+S | $105.00 | 16,954 | $1,780,170 | 43,453 | -28.1% |
| 2022-04-07 00:02 | 2022-04-04 | CVS | CVS HEALTH Corp | Finke Daniel P | Officer; EVP/Pres, Health Care Benefits | Retail-Drug Stores and Proprietary Stores | OPT+S | $100.12 | 61,300 | $6,137,197 | 32,150 | -65.6% |
| 2022-03-31 23:49 | 2022-03-30 | CVS | CVS HEALTH Corp | Shah Prem S | Officer; EVP and Co-President of Retail | Retail-Drug Stores and Proprietary Stores | OPT+S | $104.70 | 5,346 | $559,726 | 59,071 | -8.3% |
| 2022-03-18 23:55 | 2022-03-17 | CVS | CVS HEALTH Corp | Shah Prem S | Officer; EVP and Co-President of Retail | Retail-Drug Stores and Proprietary Stores | OPT+S | $106.65 | 4,624 | $493,150 | 59,071 | -7.3% |
| 2022-03-17 23:32 | 2022-03-15 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $105.00 | 51,361 | $5,392,905 | 836,751 | -5.8% |
| 2022-02-12 00:42 | 2022-02-10 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | Retail-Drug Stores and Proprietary Stores | BUY | $105.90 | 1,000 | $105,904 | 18,334 | +5.8% |
| 2022-02-05 00:46 | 2022-02-03 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $110.00 | 47,937 | $5,273,070 | 138,246 | -25.7% |
| 2022-02-03 00:20 | 2022-02-01 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP&President-PharmacyServices | Retail-Drug Stores and Proprietary Stores | OPT+S | $106.50 | 21,386 | $2,277,566 | 61,341 | -25.9% |
| 2022-02-02 00:43 | 2022-01-28 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $109.00 | 6,059 | $660,431 | 17,497 | -25.7% |
| 2022-01-29 00:58 | 2022-01-27 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer; EVP & Chief Operating Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $107.50 | 68,482 | $7,361,815 | 107,115 | -39.0% |
| 2021-11-05 23:35 | 2021-11-03 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer; EVP & Chief Operating Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $95.00 | 108,870 | $10,342,650 | 107,115 | -50.4% |
| 2021-11-03 23:44 | 2021-11-01 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $90.00 | 28,159 | $2,534,310 | 138,246 | -16.9% |
| 2021-10-28 23:34 | 2021-10-26 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $88.00 | 82,757 | $7,282,616 | 138,246 | -37.4% |
| 2021-09-08 02:57 | 2021-09-02 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $87.00 | 2,625 | $228,375 | 140,201 | -1.8% |
| 2021-08-05 23:58 | 2021-08-05 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | Retail-Drug Stores and Proprietary Stores | BUY | $79.55 | 3,000 | $238,635 | 17,334 | +20.9% |
| 2021-06-30 00:43 | 2021-06-28 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP&President-PharmacyServices | Retail-Drug Stores and Proprietary Stores | SALE | $83.67 | 2,781 | $232,686 | 61,048 | -4.4% |
| 2021-06-18 00:04 | 2021-06-15 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $86.00 | 67,552 | $5,809,472 | 142,826 | -32.1% |
| 2021-06-08 23:48 | 2021-06-07 | CVS | CVS HEALTH Corp | Finke Daniel P | Officer; EVP/Pres, Health Care Benefits | Retail-Drug Stores and Proprietary Stores | OPT+S | $86.60 | 37,594 | $3,255,640 | 23,310 | -61.7% |
| 2021-05-13 00:30 | 2021-05-10 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $86.00 | 109,469 | $9,414,334 | 0 | -100.0% |
| 2021-05-11 00:18 | 2021-05-07 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $84.00 | 9,477 | $796,068 | 144,697 | -6.1% |
| 2021-05-07 00:52 | 2021-05-04 | CVS | CVS HEALTH Corp | Boratto Eva C | Officer; EVP & CFO | Retail-Drug Stores and Proprietary Stores | SALE | $80.00 | 4,905 | $392,400 | 115,331 | -4.1% |
| 2021-04-23 23:57 | 2021-04-21 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $77.00 | 103,423 | $7,963,571 | 0 | -100.0% |
| 2021-04-02 00:31 | 2021-03-31 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $76.00 | 5,350 | $406,600 | 7,244 | -42.5% |
| 2021-03-31 00:01 | 2021-03-29 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $76.15 | 62,943 | $4,793,109 | 0 | -100.0% |
| 2021-03-30 01:55 | 2021-03-26 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer; EVP & Chief Operating Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $74.49 | 73,433 | $5,470,024 | 664 | -99.1% |
| 2021-03-30 01:53 | 2021-03-26 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director | Retail-Drug Stores and Proprietary Stores | OPT+S | $74.73 | 270,650 | $20,225,675 | 524,026 | -34.1% |
| 2021-03-24 01:15 | 2021-03-19 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | SALE | $74.15 | 49,211 | $3,648,996 | 18,226 | -73.0% |
| 2021-03-18 00:22 | 2021-03-16 | CVS | CVS HEALTH Corp | Boratto Eva C | Officer; EVP & CFO | Retail-Drug Stores and Proprietary Stores | OPT+S | $74.68 | 18,882 | $1,410,108 | 71,082 | -21.0% |
| 2021-02-18 01:04 | 2021-02-17 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | Retail-Drug Stores and Proprietary Stores | BUY | $72.00 | 3,000 | $216,000 | 14,334 | +26.5% |
| 2021-01-22 01:17 | 2021-01-19 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $77.00 | 62,893 | $4,842,761 | 523,329 | -10.7% |
| 2021-01-14 01:08 | 2021-01-12 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; EVP and Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $77.00 | 25,177 | $1,938,629 | 46,588 | -35.1% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.